The long-term goal is to provide new and improved analytical methods that will enable researchers to find gene markers genetically linked with putative genes underlying schizophrenia. This, in turn, will open the way to identifying schizophrenia genes by molecular methods. Once such genes are found, there is hope that knowledge of their structure will lead to a deeper understanding of the disease etiology and, thus, to the possibility of ameliorating or curing schizophrenia.
The specific aims consist of 1) developing efficient methods for selecting """"""""influential"""""""" single-nucleotide polymorphisms (SNPs) for localizing genes underlying psychiatric complex traits, 2) developing methodology for resampling family pedigree data under the null hypothesis of no linkage and no association, and 3) consulting and collaborating with researchers in schizophrenia (data collected through projects of other investigators). Computer programs and methods obtained through this work will be made available to researchers.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
5R01MH044292-15
Application #
6835163
Study Section
Mammalian Genetics Study Section (MGN)
Program Officer
Lehner, Thomas
Project Start
1989-05-01
Project End
2008-12-31
Budget Start
2005-01-01
Budget End
2005-12-31
Support Year
15
Fiscal Year
2005
Total Cost
$265,782
Indirect Cost
Name
Rockefeller University
Department
Biostatistics & Other Math Sci
Type
Other Domestic Higher Education
DUNS #
071037113
City
New York
State
NY
Country
United States
Zip Code
10065
Xu, Haiyan; Cheng, Rong; Juo, Suh-Hang et al. (2011) Fine mapping of candidate regions for bipolar disorder provides strong evidence for susceptibility loci on chromosomes 7q. Am J Med Genet B Neuropsychiatr Genet 156:168-76
Yuferov, Vadim; Ji, Fei; Nielsen, David A et al. (2009) A functional haplotype implicated in vulnerability to develop cocaine dependence is associated with reduced PDYN expression in human brain. Neuropsychopharmacology 34:1185-97
Levran, O; Londono, D; O'Hara, K et al. (2009) Heroin addiction in African Americans: a hypothesis-driven association study. Genes Brain Behav 8:531-40
Harris, C R; Dewan, A; Zupnick, A et al. (2009) p53 responsive elements in human retrotransposons. Oncogene 28:3857-65
Andreoli, Michael T; Morrison, Margaux A; Kim, Ben J et al. (2009) Comprehensive analysis of complement factor H and LOC387715/ARMS2/HTRA1 variants with respect to phenotype in advanced age-related macular degeneration. Am J Ophthalmol 148:869-74
He, C; Hamon, S; Li, D et al. (2009) MHC fine mapping of human type 1 diabetes using the T1DGC data. Diabetes Obes Metab 11 Suppl 1:53-9
Cheung, Kenneth M C; Karppinen, Jaro; Chan, Danny et al. (2009) Prevalence and pattern of lumbar magnetic resonance imaging changes in a population study of one thousand forty-three individuals. Spine (Phila Pa 1976) 34:934-40
Nielsen, David A; Yuferov, Vadim; Hamon, Sara et al. (2009) Increased OPRM1 DNA methylation in lymphocytes of methadone-maintained former heroin addicts. Neuropsychopharmacology 34:867-73
Long, Quan; Zhang, Qingrun; Ott, Jurg (2009) Detecting disease-associated genotype patterns. BMC Bioinformatics 10 Suppl 1:S75
Porton, Barbara; Delisi, Lynn E; Bertisch, Hilary C et al. (2008) Telomerase levels in schizophrenia: a preliminary study. Schizophr Res 106:242-7

Showing the most recent 10 out of 61 publications